ClinicalTrials.gg

Emergent BioSolutions clinical trials

The registry lists 51 studies whose lead sponsor is Emergent BioSolutions or one of 2 companies grouped under it. 7 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 7, 2026.

Our grouping of 3 registry names, not the registry’s. See them and correct one ↓

Get an email when these change. Save the Emergent BioSolutions studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

What it is testing

The drugs Emergent BioSolutions’ studies test, most studies first; none is open now — 13 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

Show 3 more

Coming up

3 of Emergent BioSolutions’ studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. 2J
  10. 1A
  11. S
  12. O
  13. N

Add all 3 to your calendar (.ics) → With an account.

All 51 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now714%Not yet recruiting 5 · Enrolling by invitation 2
  • Completed3671%
  • Stopped early714%Terminated 6 · Withdrawn 1
  • Status unknown or other12%

Phase

  • Phase 119
  • Phase 210
  • Phase 37
  • Phase 45

Where

  • United States37
  • Canada4
  • Spain2
  • France1
  • Germany1
  • United Kingdom1

Over the years

  1. 07
  2. 508
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 126

By the year each study started; 6 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Emergent BioSolutions.

  • Emergent BioSolutions
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    47 studies
  • Cangene Corporation
    Acquired — became part of Emergent BioSolutions, Feb 21, 2014 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Emergent Product Development Seattle LLC
    Divested — left Emergent BioSolutions, Aug 1, 2016 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Emergent BioSolutions leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 51. Browse all 51 →